Li-Fraumeni syndrome (LFS) is associated with many different cancers, including early onset breast cancer. Due to an increased risk of radiation-induced malignancy, radiation therapy is often avoided in this patient population. This case study evaluates a 38-year-old female with a history of juvenile granulosa cell tumor of the ovary and malignant phyllodes tumor of right breast, who subsequently developed bilateral invasive ductal carcinoma and was treated with bilateral mastectomies. Studies show that in a high-risk patient, post-mastectomy radiation therapy (PMRT) should not be ruled out due to a history of LFS, as the benefit of PMRT may outweigh the risk of a radiation-induced malignancy.
FrebourgTBajalicaLSOliveiraCMagenheimREvansD. Guidelines for the Li–Fraumeni and heritable TP53-related cancer syndromes. Euro J Hum Genet. 2020;28(10):1379-1386. doi:10.1038/s41431-020-0638-4
2.
LeANHartonJDesaiH, et al.Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome. Breast Cancer Res Treat. 2020;181(1):181-188. doi:10.1007/s10549-020-05612-7
3.
BougeardGRenaux-PetelMFlamanJM, et al.Revisiting li-fraumeni syndrome from TP53 mutation carriers. J Clin Oncol. 2015;33(21):2345-2352. doi:10.1200/JCO.2014.59.5728
4.
HendricksonPGLuoYKohlmannW, et al.Radiation therapy and secondary malignancy in Li-Fraumeni syndrome: A hereditary cancer registry study. Cancer Med. 2020;9(21):7954-7963. doi:10.1002/cam4.3427
